CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
NeuWave Microwave Ablation Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05471596
NCT05471596N/ACompleted

Prospective Analysis of In Vivo Laparoscopic Microwave Ablation Thermodynamics in Hepato-Pancreato-Biliary Solid Tumors

Wake Forest University Health Sciences·observational·Posted Jul 25, 2022·Updated Mar 4, 2024

In Brief

An observational study evaluating NeuWave Microwave Ablation System for Liver Diseases. Completed, enrolled 60 participants across 1 site.

Detailed Summary

To prospectively collect and evaluate pre-operative, intra-operative, and post-operative variables for all patients undergoing surgical microwave ablation. All patients who have a surgical microwave ablation with the Neuwave system will be added to the database after their treatment and procedures have been completed.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLiver Diseases
CountriesUnited States
CollaboratorsJohnson & Johnson

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJul 25, 2022
Enrollment StartFeb 14, 2022
Primary CompletionNov 17, 2023
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 3.9 years ago

Interventions

NeuWave Microwave Ablation Systemdevice

The NEUWAVE System supports target ablation or linear coagulation in surgical liver resection procedures. The System offers a versatile probe portfolio, multi-probe synchrony and CO2 cooling to help control the shape, size and burn pattern of your ablations.